User:Swunalightyear/sandbox: Difference between revisions
Appearance
Content deleted Content added
South Carolina bill |
clear out sandbox Tag: Replaced |
||
Line 1: | Line 1: | ||
{{User sandbox}} |
{{User sandbox}} |
||
<!-- EDIT BELOW THIS LINE --> |
<!-- EDIT BELOW THIS LINE --> |
||
=== State legislation === |
|||
Legislators in several U.S. states have pushed changes to state laws regarding naloxone co-prescribing. Many have passed and were signed into law. Examples include: |
|||
* '''California'''. Signed into law in 2018, the [[California Naloxone Requirement Bill]] requires medical prescribers to offer a prescription for naloxone (or equivalent) to certain populations at higher risk of overdosing from opiate drugs.<ref>{{Cite web|title=Bill Text - AB-2760 Prescription drugs: prescribers: naloxone hydrochloride and other FDA-approved drugs.|url=https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201720180AB2760|access-date=2020-07-22|website=leginfo.legislature.ca.gov}}</ref> |
|||
* '''Colorado'''. The [[Colorado Harm Reduction Substance Use Disorders Law]] requires that the cost of opioid antagonists such as Narcan and Evzio be covered by health insurance.<ref>{{Cite web|last=Severance|first=Ryan|title=Colorado bills addressing opioid crisis signed into law|url=https://www.chieftain.com/news/20200714/colorado-bills-addressing-opioid-crisis-signed-into-law|access-date=2020-09-02|website=The Pueblo Chieftain|language=en}}</ref><ref>{{Cite web|title=Harm Reduction Substance Use Disorders {{!}} Colorado General Assembly|url=https://leg.colorado.gov/bills/hb20-1065|access-date=2020-09-02|website=leg.colorado.gov}}</ref> |
|||
* '''Illinois'''. The [[Illinois Opioids-Covid-19-Naloxone Resolution]], a legislative bill that is still working its way through the Illinois State Senate<ref>{{Cite web|title=Illinois General Assembly - Bill Status for SR1184|url=http://www.ilga.gov/legislation/BillStatus.asp?DocNum=1184&GAID=15&DocTypeID=SR&SessionID=108&GA=101|access-date=2020-06-14|website=www.ilga.gov}}</ref>, if passed would urge the state to study the increase in opiate overdose deaths in Illinois and would urge the state to propose changes to prescription rules to include co-prescription of naloxone to patients in high-risk groups of overdose.<ref>{{Cite web|title=Illinois General Assembly - Full Text of SR1184|url=http://www.ilga.gov/legislation/fulltext.asp?DocName=&SessionId=108&GA=101&DocTypeId=SR&DocNum=1184&GAID=15&LegID=&SpecSess=&Session=|access-date=2020-06-14|website=www.ilga.gov}}</ref> |
|||
* '''New Jersey'''. Still pending in the state Senate, the [[New Jersey Opioid Antidote Prescription Bill]] would require a co-prescription of naloxone or other opioid overdose agent with prescriptions for opioid medications for all patients who have a high risk of overdosing and tightens restrictions on the dispensing of opioid medications within the state.<ref>https://www.njleg.state.nj.us/2020/Bills/S2500/2323_I1.PDF</ref> Note that this is a distinction from other bills, which would merely allow or suggest co-prescription; in this bill, it would be required. |
|||
* '''New York'''. A bill introduced in New York, the [[New York Mandatory Opioid Antagonist Prescription Bill]], would require doctors and other prescribers to co-prescribe an opioid antagonist agent with the first opioid prescription of the year for certain high-risk patients.<ref>https://legislation.nysenate.gov/pdf/bills/2019/S5150B</ref> |
|||
* '''South Carolina'''. The [[South Carolina Opioid Overdose Prevention Bill]] if passed would require prescribers to offer a prescription for naloxone (or other equivalent opioid overdose medication) to patients at high risk of an opioid overdose. Note that this bill is distinctively different than the others; it merely requires the prescriber to "offer" the prescription rather than require the prescription to be issued.<ref>{{Cite web|title=2019-2020 Bill 4711 Text of Previous Version (Feb. 20, 2020) - South Carolina Legislature Online|url=https://www.scstatehouse.gov/sess123_2019-2020/prever/4711_20200220.htm|access-date=2020-07-09|website=www.scstatehouse.gov}}</ref> |
|||
== See also == |
|||
* [[California Naloxone Requirement Bill]] |
|||
* [[Illinois Opioids-Covid-19-Naloxone Resolution]] |
|||
* [[New Jersey Opioid Antidote Prescription Bill]] |
|||
* [[New York Mandatory Opioid Antagonist Prescription Bill]] |
|||
* [[South Carolina Opioid Overdose Prevention Bill]] |
|||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
[[:Category:United States state health legislation]] |
Revision as of 14:34, 17 June 2021